Rocky Mountain High Brands President and CEO and Director

New Post Public Reply Private Reply Replies (1) Message Board
jettyjams
824
Rocky Mountain High Brands President and CEO and Director of Operations Interviewed on In the Know with Brian Glenn on 620 AM KEXB Experts in Business; Discuss Making History as Sole Provider of CBD-Infused Beverages for Sale in Mexico

DALLAS, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Rocky Mountain High Brands, Inc. (OTCQB: RMHB), a fully reporting lifestyle brand management company specializing in high-quality health and wellness products, announced today that its President and Chief Executive Officer, Michael Welch and its Director of Operations, Christian Vega were guests on In the Know with Brian Glenn on 620 AM KEXB Experts in Business on Tuesday, November 27, 2018.

Mr. Welch and Mr. Vega discussed:

-- The background of the Company's agreement with CBD Life, a subsidiary of

RCH Grupo .

-- The role that Mr. Vega played as a liaison between RMHB and CBD Life.

-- The new CBD law in Mexico and how it has created opportunities for CBD

companies.

-- The significance of the Rocket High, California Lemonade and California

Black Tea drinks produced by RMHB for CBD Life, and the fact that they

are the only drinks with permits to be imported into Mexico at the

current time.

During the interview, Brian Glenn asked Mr. Welch about Rocky Mountain High Brands other product lines, in particular HEMPd, Eagle Spirit Spring Water, and FitWhey. As a fitness enthusiast, Mr. Glenn was very interested in RMHB's new FitWhey line of protein drinks.

To view the interview, please click on the following link:

https://www.dropbox.com/s/oz2c0gmx8fd0649/ROC...X.mp4?dl=0

Rocky Mountain High Brands, Inc. (RMHB) Stock Research Links

RMHB Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Hims & Hers Health Faces Revenue Challenges and Legal Issues

Updated Category News Views 246

Hims & Hers Revenue Challenges Amid Stock Decline In recent trading sessions, Hims & Hers Health reported notable stock fluctuations as the company unveiled a decline in revenue per customer linked to its customization of GLP-1 medications for weight loss. This announcement caused an almost 11% drop in the stock price. Impacts of Collaboration Termination This steep...

Continue Reading
Entrée Resources Reports Solid Results for Q3 2025

Updated Category News Views 166

Entrée Resources Ltd. Overview Entrée Resources Ltd. (TSX: ETG; OTCQB: ERLFF), a reputable Canadian mining company focused on the Oyu Tolgoi project, has announced its interim financial results for the third quarter of 2025. This announcement sheds light on its ongoing operations and future plans, emphasizing the company's significant role in one of the world's largest...

Continue Reading
Bucket List Wine Dinners Beckon to Los Angeles

Updated Category News Views 10

Sipping on the Extraordinary: LA Wine Soiree When was the last time you had a glass of wine that truly feels like you've unlocked a treasure chest? That's what LearnAboutWine.com is going for with their bucket list wine dinners in Los Angeles. Imagine tasting some of the world's most coveted bottles, all served with a level of polish that screams high-end dining. Led by...

Continue Reading
BioLife Solutions Enhances Growth Potential with $73 Million Sale

Updated Category News Views 68

BioLife Solutions Announces $73 Million Sale of SciSafe In a significant move aimed at reinforcing its strategic direction, BioLife Solutions, Inc. (NASDAQ: BLFS), a prominent player in the development and supply of cell processing tools and services for the cell and gene therapy market, has announced the sale of its biostorage subsidiary, SciSafe Holdings, Inc. The...

Continue Reading
Advancements in Universal Vaccine Development by Dx&Vx

Updated Category News Views 154

Innovative Pathway Towards a Universal COVID-19 Vaccine In the wake of a global resurgence of COVID-19, Dx&Vx (DXVX) is stepping up its efforts to develop a universal vaccine aimed at providing protection against all variants of the virus. With the recent acquisition of cutting-edge technology, this next-generation vaccine is set to attract significant global interest....

Continue Reading